Nanotechnology has emerged as a highly influential technology in recent years [1]. It is a scientific field that employs various synthesis methods and techniques to manipulate particle sizes and configurations, creating particles ranging from one to one hundred nanometers [2]. Nanoscale particles exhibit unique characteristics, including variations in shape and size distribution, which differ significantly from those of larger particles [3].
The bottom-up method uses plant extracts to produce nanoparticles for biological applications [4]. This approach is part of the developing field of "Phyto nanotechnology," which focuses on using nanoparticles that are ecologically friendly and cost-effective [5]. For the first time in scientific research, we used a plant, Conyza canadensis, for this purpose.
Conyza is a genus classified in the Asteraceae family, encompassing approximately 400 species distributed globally [6]. Some species of this genus have been utilized in traditional medicine to treat wounds, facial acne, rheumatism, swelling, arthritis-induced pain, and various pathological conditions such as inflammation and microbial infections, including urinary and respiratory tract infections [7]. Using plants has been associated with various pharmacological activities, such as antibacterial, antioxidant, anticancer, hypolipidemic, cardiovascular, neurological, respiratory, immune system, anti-inflammatory, analgesic, and antipyretic effects [8, 9]. The effects mentioned, which display antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory, and anti-musical properties, are linked to plant secondary metabolites such as monoterpenes, diterpenes, triterpenes, tetraterpenes, sesquiterpenes, saponins, flavonoids, phenols, steroids, and coumarins [10, 11].
Phytochemical investigations have revealed that C. canadensis contains a wide range of chemical components, such as saponins, diterpenoids, terpenoids, glycosides, tannins, anthraquinones, steroids, phenols, and flavonoids [12]. C. canadensis exhibits a variety of biological activities, including antioxidant, antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, and mutagenic properties [7]. Previous research has shown that extracts from C. canadensis demonstrate strong cytotoxic effects on many cancer cell lines [13].
This research aimed to explore and expand the potential use of an aqueous extract of C. canadensis for the production of silver nanoparticles. We evaluated their impact on breast cancer cell lines (MCF7), measured the levels of anti-inflammatory cytokines IL-6 and IL-10, examined their ability to promote wound healing, and compared the effects of C. canadensis-loaded AgNPs with traditional AgNPs. However, there is no clear scientific evidence for using Conyza extract to produce silver nanoparticles for wound healing.
This study is the first novel report combining the phytochemical composition of the plant used in traditional medicine, the biosynthesis of silver nanoparticles from C. canadensis, and the ability of its extract to promote wound healing.